Naloxone is protective against indomethacin-induced intestinal ulceration in the rat

Y. Waisman, G. Dinari*, H. Marcus, M. Ligumsky, Y. Rosenbach, I. Zahavi, M. Nitzan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Naloxone, an opiate antagonist, was reported to protect against stress ulcers in dogs and rats. We studied its possible protective effect against indomethacin-induced intestinal ulceration in the rat. Naloxone was indeed found to possess a marked protective effect on the intestinal mucosa (ulcer index 73.3 ± 13.6 vs. 273.8 ± 21.8, p < 0.001). Naloxone was found to elevate basal intestinal mucosal prostaglandin E2 (p < 0.001) and cyclic adenosine monophosphate levels (p < 0.005) but was unable to overcome the inhibition of prostaglandin E2 caused by indomethacin. An increase of cyclic adenosine monophosphate levels was seen, however, even in the presence of indomethacin, suggesting that cyclic adenosine monophosphate, but not prostaglandins, may play a role in the protective effect of naloxone.

Original languageEnglish
Pages (from-to)86-91
Number of pages6
JournalGastroenterology
Volume89
Issue number1
DOIs
StatePublished - Jul 1985

Fingerprint

Dive into the research topics of 'Naloxone is protective against indomethacin-induced intestinal ulceration in the rat'. Together they form a unique fingerprint.

Cite this